First generic versions of Singulair receive FDA approval for treatment of … – News-Medical.net


MedPage Today

First generic versions of Singulair receive FDA approval for treatment of
News-Medical.net
The U.S. Food and Drug Administration today approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies. Montelukast is in
Teva asthma, allergy drug approved by FDAJerusalem Post
FDA Approves Generic Versions Of Singulair To Treat Asthma, AllergiesNASDAQ
Generic Singulair ApprovedWebMD
MedPage Today –Chicago Tribune –Columbus Dispatch
all 41 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.